Introduction {#S1}
============

Increasing antibiotic resistance, due to an overuse of antibiotics, and emergence of multidrug-resistant (MDR) pathogens prioritize research to discover new antimicrobials. The use of plants or their derivatives for prevention and treatment of various health ailments and infections is in practice from immemorial time ([@B51]): in fact, some plant extracts have antimicrobial properties able to affect different pathogens ([@B53]).

Microorganisms are naturally associated to plants in different ways ([@B49]). According to a widely used definition, "endophytic bacteria and fungi internally colonize the host tissues, sometimes in high numbers, without damaging the host or eliciting symptoms of plant disease" ([@B48]). Most of the microorganisms inhabiting plants are important for the host's development and health, despite, sometimes they could also be neutral ([@B36]; [@B45]).

Increasing knowledge indicates that microbes and/or their interactions with the host are responsible for the synthesis of natural products ([@B15]): for several medicinal plants, according to [@B22], "it is presumed that the plant-associated microbiome, especially the complex community of the endomicrobiome, is directly or indirectly involved in the production of bioactive phytochemicals". Indeed, endophytic microorganisms play an important role in searching for natural bioactive compounds, with potential use in the health sector and in drug discovery ([@B25]). It is well known that, within plant diversity, a distinctive microbiota is harbored by medicinal plant species due to their structurally divergent and unique secondary metabolites ([@B46]).

*Origanum vulgare* L. is a medicinal aromatic plant belonging to the *Lamiaceae* family, which comprises many essential oil (EO) producing species. *O. vulgare* is morphologically considered to be one of the most variable species within the genus *Origanum*. Moreover, its variability is also exhibited in the chemotype, which is highly influenced by the plant growth environment. The most represented compounds in oregano EO are phenolic monoterpenes, such as carvacrol and thymol ([@B57]; [@B12]), followed by linalool and linalyl acetate ([@B12]). Thymol and carvacrol have been reported to exert a substantial inhibitory activity against microbes ([@B26]): in fact, it is known that the antibacterial properties of EO are mainly due to its phenolic compounds ([@B10]). Other published studies report EO compositions rich in sesquiterpene hydrocarbons, such as germacrene D and β-caryophyllene ([@B39]). These two compounds are major components also in other medicinal plants EOs, such as those of *Cedrus libani* A. Rich. and *Artemisia vulgaris* L., and they are known to act as antimicrobial, anesthetic and anti-inflammatory compounds, with cytotoxic activity against several cancer cell lines ([@B50]; [@B33]). According to [@B6], the plant species (medicinal or aromatic ones) that produce EOs could represent a suitable model for "testing the hypothesis of an effect of the endophyte-microbiome dichotomy on the production of EOs and, consequently, of a colonization of plant tissues by bacteria resistant to these oils," as well as the role of plant-bacteria interaction in the modulation of medicinal plant secondary metabolism ([@B28], [@B29], [@B30]).

In this work, the chemotype of *O. vulgare* EO was determined and the cultivable bacteria from different compartments (flower, leaf, stem and soil) were isolated. The main goals were (i) to characterize the bacterial microbiota associated to the plant, determining the forces responsible for the structuring of its composition (by evaluation of cross inhibition); (ii) to investigate if bacterial endophytes demonstrate antimicrobial activities against human pathogens.

Materials and Methods {#S2}
=====================

Hydrodistillation of the Essential Oil {#S2.SS1}
--------------------------------------

A pool of three plants of *O. vulgare* L. cultivated in an open-air common garden at the "Giardino delle Erbe - Augusto Rinaldi Ceroni," Casola Valsenio (Ravenna, Italy), were collected in July 2018. 1 kg of above ground tissues was distilled. The steam distillation of EO was carried out at the Giardino delle Erbe (Casola Valsenio, RA, Italy), following the method described in [@B17].

Determination of the Essential Oil Composition {#S2.SS2}
----------------------------------------------

The pure EO was diluted at 5% in HPLC-grade *n*-hexane and then injected in the GC/EI-MS apparatus. The GC/EI-MS analyses were performed with a Varian CP-3800 apparatus equipped with a DB-5 capillary column (30 m × 0.25 mm i. d., film thickness 0.25 μm) and a Varian Saturn 2000 ion-trap mass detector. The oven temperature was programmed rising from 60 to 240°C at 3°C/min. The set temperatures were as follows: injector temperature, 220°C; transfer-line temperature, 240°C. The carrier gas was He, at 1 ml/min flow. The injection volume was set at 1 μl. The acquisition was performed with the following parameters: full scan, with a scan range of 35--300 *m/z*; scan time: 1.0 s; threshold: 1 count. The identification of the constituents was based on the comparison of their retention times (t~*R*~) with those of pure reference samples and their linear retention indices (LRIs), which were determined relatively to the t~*R*~ of a series of *n*-alkanes. The detected mass spectra were compared with those listed in the commercial libraries NIST 14 and ADAMS, as well as in a homemade mass-spectral library, built up from pure substances and components of commercial essential oils of known compositions, and in MS literature data ([@B35]; [@B21]; [@B11]; [@B55]; [@B1]; [@B2]).

Sampling of *O. vulgare* and Plant-Associated Bacteria Extraction {#S2.SS3}
-----------------------------------------------------------------

From the same pool of plants of *O. vulgare* used for hydrodistillation, plant anatomical parts (i.e., flower, leaf, stem) and soil near the plant roots (bulk soil) were separately collected and treated as independent samples. Flowers were grouped and pooled, as well as the stems and leaves. 1 g of fresh tissue from each pool was surface sterilized with 1% v/v HClO in a sterile 50 ml tube at room temperature in order to remove the epiphytic bacteria, as described in [@B7]. After this, samples were washed three times with sterile water, and then they were pottered in a sterile mortar with the addition of 2 ml of 0.9% w/v NaCl sterile solution. Water used for the last wash was plated on TSA to verify sterility of sample external surface. Bulk soil was treated separately at room temperature for 1 h with 20 ml of 10 mM Mg~2~SO~4~ in a 50 ml sterile tube under shaking, to allow the detachment of bacteria from soil particles.

Extraction of Genomic DNA and NGS Sequence Analysis {#S2.SS4}
---------------------------------------------------

Genomic DNA was extracted from flower, leaf and stem samples using PowerLyzer^®^ PowerSoil^®^ DNA Isolation Kit (MO BIO laboratories, Inc., Carlsbad, CA, United States) following the manufacturer's instruction. Hypervariable regions of bacterial 16S rRNA gene (V1--V9) ([@B5]; [@B43]) were used as molecular markers for bacterial identification in HTS analysis ([@B20]). In this study, the V3--V4 regions were sequenced using the primer 341F and 805R ([@B19]) according to the protocol reported in the 16S Metagenomic Sequencing Library Preparation protocol from Illumina ([@B23]). Library preparation and demultiplexing were performed following Illumina's standard pipeline ([@B4]). Libraries were sequenced in a single run using Illumina MiSeq technology with pair-end sequencing strategy with MiSeq Reagent Kit v3. Library construction and sequencing were performed by an external company (BMR Genomics, Padua, Italy). Sequence files have been submitted in the NCBI sequence read archive (SRA) and are available under the accession [PRJNA606513](PRJNA606513).

Amplicon Sequence Variant Inference {#S2.SS5}
-----------------------------------

Sequences were clustered into ASVs using the DADA2 pipeline reported at <https://benjjneb.github.io/dada2/tutorial.html> ([@B3]). PCR primers were removed with cutadapt ([@B34]) with default settings. Sequences were discarded if the software did not detect one or both primers (--discard-untrimmed option). To ensure that sequences were paired after the trimming process the '-pair-filter = any' option was used. Sequences were then filtered using the 'filterAndTrim' function of DADA2 with a maximum error rate of 2 and a fixed length of 270 and 200bp for forward and reverse reads, respectively. Trimmed sequences were used for error rate estimation (the 'learnErrors' function with default parameters). Finally, sequences were denoised and merged, and variants were inferred using the DADA2 algorithm. Taxonomic annotation was performed after chimera removal using DECIPHER package ([@B41]) (version 2.0) with the Silva training set 132 ([@B47]). Tables produced by the DADA2 pipeline were imported into phyloseq (through the phyloseq R package version 1.22.3), ASVs assigned to chloroplasts and mitochondria have been excluded, and bacterial communities of the three compartments were analyzed.

Count and Isolation of Cultivable Bacteria {#S2.SS6}
------------------------------------------

Tissue extracts and soil suspensions were diluted (10^--1^, 10^--3^, 10^--5^, 10^--7^) and 100 μl of each dilution were plated on tryptic soy agar (TSA) medium (Bio-Rad) in triplicate. Plates were incubated at 30°C and the CFU (colony forming units) were counted after 48 h. For each compartment about 25 different colonies were randomly chosen; then, they were streaked on TSA medium and grown at 30°C for 48 h.

Bacterial Strains and Growth Conditions {#S2.SS7}
---------------------------------------

The bacterial collection is represented by a panel of 97 isolates from different compartments of *O. vulgare* L. plants (24 isolates from flower compartment, 24 from leaf, 25 from stem and 24 from bulk soil). Isolates are referred to as OV followed by F, L, S or T for flower, leaf, stem and bulk soil districts, respectively, and numerated. Bacterial isolates were grown on TSA medium for 48 h at 30°C.

Random Amplified Polymorphic DNA Analysis {#S2.SS8}
-----------------------------------------

Cell lysates were prepared by processing a single isolated colony resuspended in 20 μl of sterile dH~2~O, by thermal lysis (95°C for 10 min), followed by cooling on ice for 5 min. RAPD profiles of the bacterial isolates were obtained using the primer 1253 ([Table 1](#T1){ref-type="table"}). The reaction mix was performed in a 25 μl-volume with 1× DreamTaq Buffer, 200 μM dNTPs, 500 ng of primer 1253, 1 U of DreamTaq DNA Polymerase (Thermo Scientific) and 2 μl of thermal lysate used as template. The PCR cycling adopted was set up in a Bio-Rad T100 thermal cycler as follows: 90°C for 1 min, 95°C for 95 s followed by 45 cycles of 95°C for 30 s, 36°C for 1 min, 75°C for 2 min, then 75°C for 10 min and finally 60°C for 10 min. Amplicons were visualized through a 2% w/v agarose gel electrophoresis. The assignment of different isolates to the same haplotype group was determined on the basis of the fingerprint pattern of each RAPD product, comparing them for the presence/absence of bands. For haplotypes represented by more than one isolate derived from the same compartment, a single bacterial isolate was randomly chosen as representative strain for that RAPD haplotype.

###### 

Primers used in this work.

  Primer   Sequence (5′ \> 3′)     Amplicon   References
  -------- ----------------------- ---------- ------------
  P0       GAGAGTTTGATCCTGGCTCAG   16S rDNA   [@B13]
  P6       CTACGGCTACCTTGTTACGA               
  1253     GTTTCCGCCC              RAPDs      [@B40]

16S rRNA Gene Sequences {#S2.SS9}
-----------------------

For each recognized RAPD haplotype, the 16S rRNA coding gene sequence was used for the taxonomic affiliation of the bacterial isolates. Amplification of 16S rDNA gene was obtained in a total volume of 20 μl, containing 1× DreamTaq Buffer, 250 μM dNTPs, 0.6 μM of primers P0 and P6 ([Table 1](#T1){ref-type="table"}), 2 U of Dream Taq DNA Polymerase (Thermo Scientific), and 1 μl of thermal lysate used as template. Samples were incubated for 3 min in a thermal cycler (Bio*-*Rad T100) at 95°C, then amplification was achieved with 30 cycles of 30 s at 95°C, 30 s at 50°C, and 1 min at 72°C, with a final extension at 72°C for 10 min. Amplicons were analyzed through a 0.8% w/v agarose gel electrophoresis. Sequencing of the 16S rDNA amplicons was performed by the Microsynth Seqlab (Germany). Each sequence was submitted to Gene Bank and the accession numbers from No [MN811044](MN811044) to No [MN811099](MN811099) ([Supplementary Table S1](#DS1){ref-type="supplementary-material"}).

Phylogenetic Tree Analysis {#S2.SS10}
--------------------------

Taxonomic affiliation of the strains was determined through the analysis of 16S rRNA gene sequences obtained. They were aligned to those of type strains retrieved from the Ribosomal Database Project (RDP) ([@B9]) using BioEdit ([@B16]). The obtained alignment was then used to build a phylogenetic tree through MEGA X ([@B24]) for each genus, applying the Neighbor-Joining algorithm with a 1000-bootstrap resampling.

Antibiotics Resistance Profile of Cultivable Bacteria Associated to *O. vulgare* {#S2.SS11}
--------------------------------------------------------------------------------

Evaluation of antibiotic resistance was performed by streaking each strain on TSA medium containing different concentration of selected antibiotics, according to [@B37]. The chosen antibiotics were chloramphenicol, ciprofloxacin, rifampicin, streptomycin, kanamycin, and tetracycline ([Table 2](#T2){ref-type="table"}). After growing on TSA medium for 48 h at 30°C, a colony of each strain was suspended in 100 μl saline solution (0.9% w/v NaCl), streaked on TSA medium supplemented with different antibiotics and then incubated at 30°C for 48 h. The following antibiotic concentrations (μg/ml) were tested: chloramphenicol (1-2.5-5-10-25-50); ciprofloxacin, streptomycin and kanamycin (0.5-1-2.5-5-10-50); rifampicin (5-10-25-50-100); tetracycline (0.5-1.25-2.5-5-12.5-25). The different growth levels were indicated as follows: complete growth (+ +), strong (+), weak (+ −), very weak (+ −), and absence of growth (−), and MIC (Minimal Inhibiting Concentration) values were identified.

###### 

Classes and targets of the antibiotics used in this work.

  Antibiotic        Class              Target
  ----------------- ------------------ ----------------
                                       
  Chloramphenicol   Phenicols          Ribosome
  Ciprofloxacin     Fluoroquinolones   Topoisomerases
  Kanamycin         Aminoglycosides    Ribosome
  Rifampicin        Ansamycins         RNA polymerase
  Streptomycin      Aminoglycosides    Ribosome
  Tetracycline      Tetracyclines      Ribosome

Analysis of Antagonistic Interactions Through Cross-Streaking {#S2.SS12}
-------------------------------------------------------------

Bacterial strains isolated from each compartment of *O. vulgare* plants were tested for cross antagonism, using representatives of each RAPD haplotype. Antagonistic interactions were assayed between each compartment of *O. vulgare* within-niche and cross-niche. Tester strains were firstly streaked across one half of a TSA plate and grown at 30°C for 48 h in order to allow the possible production of antimicrobial compounds. Target strains were then streaked perpendicularly to the tester strain and plates were incubated at 30°C for further 48 h. Additionally, target strains were grown at 30°C for 48 h in the absence of the tester, as growth control. The antagonistic effect was evaluated as the absence or reduction of the target strains growth compared to their growth in the absence of the tester strain. The different inhibition levels were indicated with numbers from 0 to 3 as follows: complete (3, red), strong (2, orange), weak (1, salmon), and absence (0, white) of inhibition ([@B32]).

Inhibition of Human Pathogens by *O. vulgare* Associated Bacteria {#S2.SS13}
-----------------------------------------------------------------

A panel of selected strains of *O. vulgare* for which high antagonistic interactions were evidenced, was tested against 46 pathogenic strains: 10 for *Staphylococcus aureus*, 10 for Coagulase-negative staphylococci, 10 for *Pseudomonas aeruginosa*, 6 for *Klebsiella pneumoniae* characterized by their resistance to multiple antibiotics (as reported in [Table 3](#T3){ref-type="table"}), and 10 of a *Burkholderia cepacia* complex (BCC) collection, MDR BCC bacteria able to resist to different antibiotic classes (e.g., polymyxins, most of beta-lactams and aminoglycosides) ([@B52]). The bacterial strains were isolated from different sources (hospital devices, foods, patients, healthy subjects, environment), as shown in [Table 3](#T3){ref-type="table"}. As reported in the BCCM/LMG bacteria collection database, origins of the BCC strains classified as environmental are the following: LMG1222, onion; LMG17588, soil; LMG19182, pea rhizosphere; LMG19230, wheat roots. Each strain was maintained at −80°C under glycerol (25%, v/v) stock, cultured in Brain Heart Infusion Broth (Thermo Scientific) for 24 h at 37°C, then streaked on TSA, and incubated at 37°C for 24 h before the use. The isolated bacterial strains (*S. aureus*, CoNS, *P. aeruginosa, K. pneumoniae*) were provided from the Applied Microbiology laboratory (Health Sciences Dept., University of Florence, Italy), while the standard bacteria *Staphylococcus aureus* ATCC 25923, *Pseudomonas aeruginosa* ATCC 27853 and *Klebsiella pneumonia* ATCC 700603 were obtained from Thermo Fisher Diagnostics S.p.A. The antimicrobial activity was evaluated through the cross-streak method, as previously described, except for the incubation temperature of target strains: 48 h at 37°C for CoNS (Coagulase-negative staphylococci) and 24 h at 37°C for all the other pathogens. The degree of antagonistic effect was evaluated by measuring the inhibition or reduction zone and the results were presented with numbers from 0 to 3 as previously described. The sum of numbers of each bacterial strain represents the total score of inhibition (TSI) ability against human pathogens. TSI was scored as absence of activity (TSI = 0), very low activity (TSI = 1--10), low activity (TSI = 11--20), strong activity (TSI = 21--27), and very strong activity (TSI = 28--30) ([@B32]).

###### 

Pathogenic strains used in the study and related antibiotic resistance profiling.

  Pathogens           Strain code   Origin   Antibiotic resistance profiling
  ------------------- ------------- -------- --------------------------------------------------------------------
  *S. aureus*         ATCC 25923    −        P, NA
                      2668          F        AMP, P, DA, TE, E, K, NA
                      2749          HS       VA, TEC, DAP
                      3709          F        DA, TE, E, K, NA
                      3710                   DA, TE, E, K, NA
                      4070                   P, DA, TE, E, CIP, LEV, DAP
                      4168                   AMP, P, DA, SXT, TE, NA
                      4302                   P, FOX, SXT, DAP
                      4691          P        P, FOX, E, CN, CIP, LEV, DAP
                      4708                   P, FOX, CN, VA, DAP
  *S. haemolyticus*   5284          HD       P, TE, E, CN, FD
                      5285                   E, CN, CIP, LEV, FD
                      5383                   P, FOX, TE, E, CN
                      5396          HS       P, FOX, SXT, CN, FD
  *S. epidermidis*    5318          HS       P, E, CN, FD
                      5321                   P, E, CN, AK, FD
                      5323                   P, TE, TIG, E, CN
                      5377          HD       P, TE, E, TEC
                      5403          HS       P, E, TIG, TE
                      5419          F        FOX, DA, CIP, LEV, SXT, TIG
  *P. aeruginosa*     ATCC 27853    −        FOX, K
                      4177          HD       AK, TOB, CIP, LEV, CAZ, FEP, MEM, IPM, ATM, PRL, TZP
                      4189                   AK, TOB, CIP, LEV, CAZ, FEP, MEM, IPM, PRL, TZP
                      5234                   AK, CAZ, ATM, TZP, PRL, FEP, CN, IPM, MEM, LEV, CIP, TOB
                      5245                   CAZ, ATM, PRL, FEP, CN, LEV, CIP, IPM, MEM, TOB
                      5246                   CAZ, ATM, TZP, PRL, FEP, CN, IPM, MEM, LEV, CIP, TOB
                      5255                   AK, ATM, CN, FEP, TOB
                      5139                   CIP, CN, FEP, LEV, TOB
                      5009                   ATM, CAZ, CIP, CN, FEP, IPM, LEV, MEM, PRL, TOB, TZP
                      5236                   AK, ATM, CAZ, CIP, FEP, IPM, LEV, MEM, TOB
  *K. pneumoniae*     ATCC 700603   −        CAZ, AMP, ATM, PRL, TE
                      4409          P        AK, AMX, FEP, CTX, CAZ, CIP, ETP, IPM, MEM, TZP, SXT, FFL, CL, TIG
                      4412                   AMX, FEP, CTX, CAZ, CIP, ETP, IPM, MEM, TZP, SXT, FFL, TIG
                      4417                   AK, AMX, FEP, CTX, CAZ, CIP, ETP, IPM, MEM, TZP, SXT, FFL, CL, TIG
                      4420                   AK, AMX, FEP, CTX, CAZ, CIP, IPM, MEM, TZP, SXT, FFL, CL, CN
                      4422                   AK, AMX, FEP, CTX, CAZ, CIP, ETP, IPM, MEM, TZP, SXT, FFL
  *B. cepacia*        FCF3          CF       
  *B. cenocepacia*    FCF23                  
  *B. multivorans*    LMG13010               
  *B. ambifaria*      LMG_16656              
  *B. cenocepacia*    LMG_21462              
  *B. cenocepacia*    LMG_24506              
  *B. cepacia*        LMG_1222      E        
  *B. multivorans*    LMG_17588              
  *B. ambifaria*      LMG_19182              
  *B. cenocepacia*    LMG_19230              

F = food, HD = hospital devices, HS = healthy subjects, P = patients, CF = Cystic Fibrosis, E = environment. Amikacin (AK), Amoxicillin (AMX), Ampicillin (AMP), Aztreonam (ATM), Cefepime (FEP), Cefotaxime (CTX), Cefoxitin (FOX), Ceftazidime (CAZ), Ciprofloxacin (CIP), Clindamycin (DA), Colistin (CL), Daptomycin (DAP), Ertapenem (ETP), Erythromycin (E), Florfenicol (FFL), Fusidic Acid (FD), Gentamicin (CN), Imipenem (IPM), Kanamycin (K), Levofloxacin (LEV), Meropenem (MEM), Nalidixic Acid (NA), Penicillin G (P), Piperacillin (PRL), Piperacillin/Tazobactam (TZP), Sulfamethoxazole/Trimethoprim (SXT), Teicoplanin (TEC), Tetracycline (TE), Tigecycline (TIG), Tobramycin (TOB), Vancomycin (VA).

Results {#S3}
=======

Chemical Characterization of the *O. vulgare* L. Essential Oil and Chemotype Attribution {#S3.SS1}
----------------------------------------------------------------------------------------

The complete composition of the EO hydrodistilled from the analyzed *O. vulgare* specimen is reported in [Supplementary Table S2](#DS1){ref-type="supplementary-material"}. Terpene hydrocarbons dominated the composition, since they were detected in a relative amount accounting for over 90% of the total. Sesquiterpene hydrocarbons, in particular, added up to over 70% of the total: among them, germacrene D and β-caryophyllene were the most abundant, exhibiting relative abundances of 29.4 and 19.2%, respectively. The plant was, thus, a germacrene D/β-caryophyllene chemotype. The oxygenated terpenes were far less represented, accounting only for the remaining 8.6%: among them, only 4-terpineol, caryophyllene oxide and spathulenol exhibited relative concentrations higher than 1%.

Characterization of the Plant Microbiota {#S3.SS2}
----------------------------------------

Bacterial communities of plant samples of the same compartments from which the EO of *O. vulgare* plants was obtained (i.e., flower, leaf, and stem) were examined through NGS. Quality filtering steps obtained a total of 53 ASVs, and representative sequences for each ASV were classified into 28 genera belonging to 4 phyla according to the Silva database, with a different distribution between leaves (with only one genus, *Acinetobacter*, found) and the other two compartments. The majority of the ASVs (62.26%) belong to *Proteobacteria* phylum, followed by *Firmicutes* (15.09%), *Actinobacteria* (11.32%), and *Bacteroidetes* (11.32%). Data obtained are shown in [Figure 1](#F1){ref-type="fig"}.

![Bar plot showing the relative abundances of bacterial genera in each sample. OVF = flower, OVL = leaf, OVS = stem compartment.](fmicb-11-00862-g001){#F1}

Isolation of Cultivable Bacteria {#S3.SS3}
--------------------------------

Bacteria extracted from flower, leaf, stem of *O. vulgare* plants and bulk soil were plated as described in Materials and Methods. Data obtained revealed that the highest bacterial titers were detected in the soil (5.1 × 10^5^), while the lowest CFU/g value was represented by the leaves (7 × 10^2^); flower and stem compartments had 2.16 × 10^5^ and 8.5 × 10^3^ CFU/g, respectively.

Strain-Level Profiling of Isolates {#S3.SS4}
----------------------------------

To investigate the structure of the culturable microbiota and to define the haplotypes (i.e., individual genotypes) present, a RAPD analysis was performed assuming that isolates sharing the same RAPD fingerprinting correspond to the same strain ([@B7] and references therein): a total of 62 different RAPD haplotypes was identified, corresponding to 62 different bacterial strains. The distribution of the RAPD haplotypes within the different compartments is shown in [Supplementary Table S3](#DS1){ref-type="supplementary-material"}. The highest number of haplotypes was detected in the stem compartment (19 haplotypes out of 25 bacterial isolates), while the soil compartment exhibited the lowest number of haplotypes (12 haplotypes out of 24 isolates) as shown in [Table 4](#T4){ref-type="table"}. Notably, a very low number of haplotypes was shared between the different compartments: indeed, only 2 strains were shared by the leaf and stem compartments.

###### 

Distribution of bacterial haplotypes, species, and genera detected in the four districts of *O. vulgare* plant.

                            Flower (OVF)   Leaf (OVL)   Stem (OVS)   Soil (OVT)   Total   \%   
  ------------------------- -------------- ------------ ------------ ------------ ------- ---- -----
  N. of isolates            24             24           25           24           97      /    
  N. of haplotypes          16             17           19           12           62      /    
  N. of species             11             13           13           9            32      /    
  N. of genera              8              8            8            6            19      /    
  N. of shared haplotypes   Flower         −            0            0            0       2    3.2
                            Leaf           −            −            2            0            
                            Stem           −            −            −            0            
                            Soil           −            −            −            −            
  N. of shared species      Flower         −            1            3            2       9    28
                            Leaf           −            −            5            4            
                            Stem           −            −            −            5            
                            Soil           −            −            −            −            
  N. of shared genera       Flower         −            2            3            1       7    37
                            Leaf           −            −            5            0            
                            Stem           −            −            −            1            
                            Soil           −            −            −            −            

Taxonomic Assignment of Strains {#S3.SS5}
-------------------------------

The taxonomic identification of strains from RAPD haplotyping by 16S rRNA gene sequencing is summarized in [Figure 2](#F2){ref-type="fig"}.

![Composition of cultivable bacterial communities of *O. vulgare*. Number of genera for each district: flower (8), leaf (8), stem (8), soil (6).](fmicb-11-00862-g002){#F2}

This analysis revealed that: (i) strains were affiliated to 19 different bacterial genera (42.1% Gram negative, 57.9% Gram positive); (ii) the majority of the 16S rDNA gene sequences was affiliated to the genus *Bacillus* (28.12%); (iii) *Arthrobacter* was the second most highly represented genus (14.06%); (iv) seven genera (*Pseudomonas, Sphyngomonas, Curtobacterium, Arthrobacter, Bacillus, Staphylococcus, Rhodococcus*) were shared among compartments, however just the genus *Bacillus* was shared by all the four districts. Moreover, a total of 12 genera were represented in only a single district, such as *Pantoea, Rhizobium, Paenibacillus, Micrococcus*, and *Rathayibacter*, which were detected only in the flower compartment ([Figure 3](#F3){ref-type="fig"}).

![Bacterial genera shared by the different anatomical parts of the plant and in the bulk soil. The number of different genera identified is reported in brackets.](fmicb-11-00862-g003){#F3}

For each genus a 16S rRNA gene phylogenetic tree was constructed as described in Materials and Methods. The analysis of the obtained phylogenetic trees (shown in [Supplementary Material](#DS1){ref-type="supplementary-material"} from [Figures S1](#DS1){ref-type="supplementary-material"} to [Figure S18](#DS1){ref-type="supplementary-material"}) allowed to affiliate the 62 strains to 32 (possible) different species. The 28.1% of species resulted to be shared by the flower, leaf, stem, and soil compartments. Only one species (i.e., *Bacillus megaterium*) resulted to be shared between all the four districts. The compartments with the highest number of species were leaf and stem districts (for both of them 13 different species were identified).

Antibiotics Resistance Profiles {#S3.SS6}
-------------------------------

The antibiotic resistance profiles of bacteria associated to the four *O. vulgare* compartments were investigated, as described in Materials and Methods. The Minimal Inhibitory Concentration (MIC) of each antibiotic was evaluated and the values are reported in [Table 5](#T5){ref-type="table"}. The 45.16% of the *O. vulgare* associated bacteria showed MIC value for the antibiotic streptomycin \< 2.5 μg/ml, and the 37.09% showed a very high MIC level (50 μg/ml). Regarding the antibiotic kanamycin the 41.93% revealed MIC value at the maximum concentration used or more. In particular, a very high tolerance to streptomycin and kanamycin, even to the highest concentrations used (MIC values \> 50 μg/ml), was revealed by some strains associated to the bulk soil and leaves. MIC value for tetracycline was evaluated at low concentrations (\< 2.5 μg/ml) for the majority of the strains (83.87%). Some strains showed the capacity to grow in presence of low concentrations of chloramphenicol and ciprofloxacin, and only a few strains (12 out of 62) demonstrated to tolerate the lowest concentrations (5 μg/ml) of rifampicin as well. Moreover, the 89.40% of the bacteria associated to the stem were almost totally inhibited by streptomycin, even at the lowest concentration. The different antibiotic resistance profiles seemed to not correlate with the species affiliation and/or the districts from whom bacteria were isolated. Nonetheless, just in case of streptomycin resistance of *Arthrobacter* strains, those isolated from the stem were much more sensitive in comparison to those ones associated to the leaves. Overall, strains associated to the bulk soil resulted tolerant to the great majority of the antibiotics tested, even at the highest concentrations used.

###### 

Antibiotic resistance assay of *O. vulgare* associated bacteria.

  Compartment   Strain   Taxonomy               MIC (μg/ml)                                   
  ------------- -------- ---------------------- ------------- -------- ------- ------- ------ -----
  T             OVT1     *Agrobacterium*        \>50          2.5      \<0.5   50      25     10
  T             OVT8     *Agrobacterium*        \>50          2.5      \<0.5   50      25     10
  T             OVT17    Agrobacterium          \>50          2.5      \<0.5   50      25     10
  T             OVT2     Agromyces              \>50          \>25     50      \>50    10     \<5
  S             OVS8     *Arthrobacter*         \<0.5         \<0.5    5       50      \<1    \<5
  S             OVS18    *Arthrobacter*         \<0.5         \<0.5    5       \>50    \< 1   \<5
  S             OVS23    *Arthrobacter*         \<0.5         1.25     2.5     50      \<1    \<5
  L             OVL1     *Arthrobacter*         \>50          \< 0.5   10      \>50    \< 1   \<5
  L             OVL3     *Arthrobacter*         50            \<0.5    5       \> 50   \< 1   \<5
  L             OVL4     *Arthrobacter*         50            \<0.5    2.5     \>50    \< 1   \<5
  L             OVL20    *Arthrobacter*         50            \<0.5    5       \> 50   \< 1   \<5
  L             OVL22    *Arthrobacter*         50            \<0.5    5       \> 50   \< 1   \<5
  T             OVT23    *Arthrobacter*         50            \<0.5    5       \> 50   2.5    \<5
  L             OVL7     *Bacillus*             \<0.5         \<0.5    \<0.5   \<0.5   2.5    \<5
  L             OVL8     *Bacillus*             5.0           \<0.5    \<0.5   1       5      \<5
  S             OVS6     *Bacillus*             \<0.5         \<0.5    \<0.5   \<0.5   10     \<5
  S             OVS10    *Bacillus*             \<0.5         2.5      \<0.5   \<0.5   2.5    \<5
  S             OVS21    *Bacillus*             \<0.5         2.5      \<0.5   \<0.5   2.5    \<5
  F             OVF22    *Bacillus*             2.5           2.5      \<0.5   \<0.5   \<1    \<5
  L             OVL9     *Bacillus*             2.5           1.25     \<0.5   1       \<1    \<5
  S             OVS26    *Bacillus*             2.5           1.25     \<0.5   2.5     2.5    \<5
  T             OVT16    *Bacillus*             2.5           2.5      \<0.5   \<0.5   10     \<5
  T             OVT24    *Bacillus*             2.5           1.25     \<0.5   \<0.5   2.5    \<5
  L             OVL12    *Bacillus*             10            5        \<0.5   1       \<1    \<5
  T             OVT5     *Bacillus*             10            \<0.5    \<0.5   2.5     2.5    \<5
  F             OVF21    *Bacillus*             50            2.5      \<0.5   10      2.5    \<5
  S             OVS24    *Bacillus*             \>50          \< 0.5   \<0.5   5       2.5    \<5
  T             OVT10    *Bacillus*             50            \<0.5    \<0.5   5       2.5    \<5
  T             OVT20    *Bacillus*             50            5        \<0.5   10      2.5    \<5
  L             OVL16    *Cellulosimicrobium*   \>50          12.5     50      \>50    10     \<5
  T             OVT9     *Chryseobacterium*     \>50          \>25     1       \>50    \>50   \<5
  S             OVS2     *Curtobacterium*       \<0.5         2.5      2.5     \>50    2.5    \<5
  S             OVS11    Curtobacterium         \<0.5         12.5     50      \>50    \< 1   \<5
  S             OVS12    *Curtobacterium*       \<0.5         12.5     50      \>50    \< 1   \<5
  S             OVS13    *Curtobacterium*       \<0.5         2.5      50      50      \<1    \<5
  S             OVS15    *Curtobacterium*       \<0.5         12.5     50      \>50    \< 1   \<5
  L             OVL10    *Curtobacterium*       2.5           1.25     \<0.5   10      \<1    \<5
  S             OVS27    *Lysinibacillus*       \>50          1.25     2.5     1       2.5    10
  L             OVL14    *Microbacterium*       5             12.5     5       \>50    \< 1   \<5
  F             OVF19    *Micrococcus*          10            1.25     5       50      \<1    \<5
  F             OVF24    *Micrococcus*          \>50          1.25     5       50      \<1    \<5
  F             OVF3     *Paenibacillus*        2.5           \<0.5    \<0.5   \<0.5   2.5    10
  F             OVF10    *Paenibacillus*        2.5           2.5      \<0.5   \<0.5   \<1    \<5
  F             OVF2     *Pantoea*              10            2.5      \<0.5   10      2.5    10
  F             OVF14    *Pantoea*              10            2.5      \<0.5   10      2.5    10
  F             OVF1     *Pantoea*              \>50          2.5      \<0.5   10      2.5    10
  F             OVF9     *Pantoea*              50            2.5      \<0.5   10      2.5    10
  F             OVF11    *Pantoea*              50            2.5      \<0.5   5       2.5    10
  F             OVF4     *Pseudomonas*          5             2.5      \<0.5   2.5     25     \<5
  L             OVL17    *Pseudomonas*          5             2.5      \<0.5   1       25     \<5
  S             OVS9     *Pseudomonas*          \<0.5         2.5      \<0.5   2.5     25     10
  S             OVS14    *Pseudomonas*          \<0.5         1.25     \<0.5   \<0.5   25     10
  F             OVF7     *Pseudomonas*          2.5           \<0.5    \<0.5   \<0.5   2.5    \<5
  F             OVF17    *Rathaybacter*         2.5           \<0.5    2.5     10      \<1    \<5
  F             OVF6     *Rhizobium*            5             2.5      \<0.5   50      2.5    \<5
  S             OVS20    *Rhodococcus*          \<0.5         2.5      \<0.5   10      \<1    \<5
  F             OVF18    *Rhodococcus*          2.5           2.5      \<0.5   5       \<1    \<5
  S             OVS7     *Sphingomonas*         \<0.5         \<0.5    1       \<0.5   \<1    \<5
  L             OVL6     *Sphingomonas*         50            \< 0.5   \<0.5   10      2.5    \<5
  S             OVS22    *Staphylococcus*       \<0.5         1.25     1       \>50    2.5    \<5
  T             OVT21    *Staphylococcus*       10            \<0.5    \<0.5   \>50    2.5    \<5
  L             OVL18    *Xanthomonas*          50            5        \<0.5   10      5      \<5

MIC values are reported as μg/ml. Str = Streptomycin, Tet = Tetracycline, Cip = Ciprofloxacin, Kan = Kanamicin, Chl = Chloramphenicol, Rif = Rifampicin. F = flower, L = leaf, S = stem, T = soil compartment.

Antagonistic Interaction Between *O. vulgare* Associated Bacteria {#S3.SS7}
-----------------------------------------------------------------

Antagonistic interactions, at both inter- and intra-compartment level, were tested through cross-streak test, as described in Materials and Methods. To this purpose, each strain was used either as a tester or target. The antagonistic effect was indicated by the absence or reduction of the target strain growth. Data obtained, schematically shown in [Figure 4](#F4){ref-type="fig"}, revealed that: (i) all the tested strains were able to inhibit at least one strain; (ii) soil-associated bacteria revealed a higher capacity to inhibit strains belonging to the other compartments, with those from stem and leaf following; (iii) flowers associated bacteria revealed the lowest capacity to inhibit other strains; (iv) regarding the inhibition sensitivity, the highest values were obtained from stem compartment, with leaf and flower following; and (v) the lowest inhibition sensitivity was revealed by soil-associated bacteria, as they were less inhibited by strains extracted from the different anatomical part of the plants.

![Heatmap showing the antagonistic interactions existing between endophytic (flower, leaf, stem) and soil bacteria isolated from the medicinal plant *O. vulgare*. Each strain was tested either as tester or target strain versus all the other ones. The inhibition values reflect three different inhibition levels observed during the cross-streak experiments, that is: complete (3, red), strong (2, orange), weak (1, salmon), and absence (0, white) of inhibition. Nd (not detected) refers to results that were not obtained.](fmicb-11-00862-g004){#F4}

[Figure 5](#F5){ref-type="fig"} shows a representation of the inhibitory pattern among strains from the same and different compartments. In this scheme, each node represents a plant compartment whereas numbers indicate the sum of the inhibiting scores of the bacteria isolated from those compartments and the inhibition potential of tester strains calculated as the sum of inhibition scores divided by the tester number. Inhibition patterns were represented by directed links, while the occurrence and the extent of self-inhibition were reported with dashed links.

![Schematic representation of inhibiting activity of bacterial strains isolated from the medicinal plant *O. vulgare* bulk soil (T), stem (S), leaf (L) and flowers (F). Each node represents a plant compartment whereas numbers represent the sum of the inhibiting scores of the bacteria isolated from those compartments **(A)** and the inhibition potential of the tester strains calculated as the sum of inhibition scores divided by the tester number **(B)**. Directed links represent inhibition patterns. Dashed links indicate the occurrence and the extent of self-inhibition.](fmicb-11-00862-g005){#F5}

The analysis of these results suggested that the bacterial communities from stem and soil were much more able to antagonize the growth of bacteria belonging to the other two compartments ([Table 6](#T6){ref-type="table"}). The relative degree of inhibitory score and sensitivity score of strains belonging to different compartments are respectively as following: soil \> stem [\>]{.ul}leaves \> flowers; soil \< stem [\<]{.ul}flowers \< leaf. Additionally, stem community showed the highest self-inhibition, whereas flower-associated bacteria revealed the lowest one. So, the different antagonistic activity observed could be, apparently, influenced by the ecological niche inhabited by bacteria.

###### 

Inhibitory and sensitivity score of the endophytic bacteria associated to the four compartments of *O. vulgare*.

  Compartment   Inhibitory score   Sensitivity score
  ------------- ------------------ -------------------
  Soil          63.41              20.25
  Stem          47.62              47.99
  Leaf          44.21              56.26
  Flowers       32.27              46.39

Inhibition of Human Pathogens by *O. vulgare* Associated Bacteria {#S3.SS8}
-----------------------------------------------------------------

The endophytic strains ([Table 7](#T7){ref-type="table"}) exhibiting high antagonistic interactions, have been further tested against human pathogens through cross-streak method, as described in Materials and Methods.

###### 

*O. vulgare* associated bacteria tested against 46 pathogenic strains.

  Compartment   Strain code   Taxonomy
  ------------- ------------- --------------------
  Flower (F)    OVF 10        *Paenibacillus*
                OVF 22        *Bacillus*
                OVF11         *Pantoea*
                OVF 6         *Rhizobium*
                OVF 1         *Pantoea*
                OVF 24        *Micrococcus*
  Leaf (L)      OVL 9         *Bacillus*
                OVL 1         *Arthrobacter*
                OVL 12        *Bacillus*
                OVL 18        *Xanthomonas*
  Stem (S)      OVS 6         *Bacillus*
                OVS 8         *Arthrobacter*
                OVS26         *Bacillus*
                OVS 2         *Curtobacterium*
                OVS10         *Bacillus*
                OVS 23        *Arthrobacter*
                OVS 9         *Pseudomonas*
                OVS 18        *Arthrobacter*
                OVS 21        *Bacillus*
  Soil (T)      OVT 9         *Chryseobacterium*
                OVT 1         *Agrobacterium*
                OVT 2         *Agromyces*
                OVT 10        *Bacillus*

In [Figure 6](#F6){ref-type="fig"} the antagonistic interactions of *O. vulgare* tester strains against 46 human pathogens are shown.

![Antagonistic interactions of *O. vulgare* associated strains against human pathogenic strains. The inhibition values reflect three different inhibition levels observed during the cross-streak experiments, that is, complete (3, red), strong (2, orange), weak (1, salmon), and absence (0, white) of inhibition. Nd (not detected) refers to results that were not obtained. TSI refers to the total score of inhibition.](fmicb-11-00862-g006){#F6}

Interestingly, focusing on the antagonistic activity against BCC, *O. vulgare* strains were much more able to inhibit the growth of BCC members isolated from CF patients than those of environmental origins ([Figure 7](#F7){ref-type="fig"}). All the flower testers exhibited a low total score of inhibition (TSI = 11--20), the 50% of leaves tester a strong TSI (TSI = 21--27), the 44.5% of stem tester a strong or very strong TSI (TSI = 21--27, 28--30), all the soil testers had a strong or very strong total score of inhibition (TSI = 21--27, 28--30).

![Antagonistic interactions of *O. vulgare* associated strains against *BCC* strains.](fmicb-11-00862-g007){#F7}

Focusing on the antagonistic activity against *S. aureus*, CoNS, *P. aeruginosa, K. pneumoniae*, among the 23 endophytes strains screened for antimicrobial activity, 11 (47.8%) showed antagonistic activity against at least one human pathogenic strain ([Figure 6](#F6){ref-type="fig"}). This preliminary test demonstrated that 54.5% of the inhibitory strains belong to *Bacillus* genera, 27.3% to *Arthrobacter* and the remaining 18.2% to *Paenibacillus* and *Chryseobacterium* genera. Moreover, the interaction among inhibitory endophytes and pathogens gave better antagonistic results for Gram-positive bacteria (25.9%) than for Gram-negative bacteria (3.98%). The obtained data revealed that the major effect was recorded against the CoNS strains; the inhibitory interactions observed against this group of bacteria, indeed, were strong or complete in most cases (83.8%). In particular, the multidrug resistant strains *S. epidermidis* 5323, 5377 and 5321 were strongly inhibited by the endophytic isolates. Finally, stem-associated bacteria revealed the highest ability to inhibit pathogenic strains, while bulk soil associated bacteria revealed the lowest ability of inhibition. [Figure 8A](#F8){ref-type="fig"} shows the percentage of the antagonistic activity exhibited by endophytes isolates against human pathogenic bacteria. OVS 26 showed broad spectrum of antagonistic activity against *S. aureus* and CoNS isolates (90% and 100%, respectively); the endophytes OVF 10, OVL 9, OVS 6 and OVT 9 showed the capacity to be active against four strains of *K. pneumoniae* (from 16.7 to 33.3%), while just OVS 8 was able to inhibit one *P. aeruginosa* strain. In general, all the eleven inhibitory endophytes showed degrees of antagonism against CoNS from 10 to 100%. [Figure 8B](#F8){ref-type="fig"} shows the TSI of the antagonistic activity exhibited by endophytes strains against *S. aureus*, CoNS, *P. aeruginosa, K. pneumoniae* human pathogenic bacteria.

![Antagonistic activity exhibited by endophytes strains against human pathogenic bacteria (*S. aureus*, CoNS, *P. aeruginosa, K. pneumoniae*) expressed as percentage of the antagonistic activity **(A)** and TSI **(B)**.](fmicb-11-00862-g008){#F8}

Discussion and Conclusion {#S4}
=========================

The potential of endophytes from medicinal plants to produce antibacterial, anticancer, and antifungal compounds is an emerging area in the last years ([@B38]; [@B32]; [@B8]; [@B31]). *O. vulgare* is an aromatic and medicinal plant, whose EO has been extensively studied because of its diverse compositions among different specimens and remarkable characteristics ([@B27]). Ecological and environmental effects, along with genetic variability, are some of the various reasons why EOs of *Origanum* species show major differences in their chemical composition ([@B56]). The studied specimen, in particular, exhibited a germacrene D/β-caryophyllene chemotype, showing a predominance of the sesquiterpene hydrocarbon fraction. Other than the volatile compounds, the aerial parts of *O. vulgare* contain a remarkable variety of therapeutic bioactive compounds, including phenolic glycosides, flavonoids, tannins, sterols and high amounts of terpenoids ([@B44]).

The analysis of the total microbiota, obtained though NGS analysis, revealed that flower and stem compartments host a similar endophytic community, with a high diversity of genera; on the contrary, the leaf compartment appears to be very less diverse, containing only *Acinetobacter* genus.

The cultivable bacterial load in *O. vulgare* different districts ranged from about 10^2^ to 10^5^ CFU/g of soil, stem, leaf and flowers (fresh weight); these data are in agreement with previous reports on other different medicinal plant species ([@B14]; [@B6]).

The analysis of the structure of bacterial communities revealed that the dataset obtained with RAPD analysis highlights a high level of biodiversity at the strain level, especially regarding the anatomical parts of the plant. On the contrary, fingerprinting of the isolates associated to the bulk soil revealed a more clonal community. Moreover, a very low degree of sharing (3.1%) between the different compartments was revealed (only two haplotypes were shared between the leaf and the stem compartments), in agreement with data reported by [@B7] about cultivable bacterial communities isolated from *Echinacea purpurea* (L.) Moench and *Echinacea angustifolia* (DC.).

The different genera identified through 16S rDNA gene amplification in *O. vulgare* plant have been detected in other plant species too, such as *E. purpurea* and *E. angustifolia* ([@B7]). In this work, *Bacillus* resulted to be the most represented genus and it was present in all districts analyzed, while other genera were exclusively present in specific ones. Overall, the RAPD and 16S rRNA gene analysis revealed that the selection of bacteria mainly occurs at the strain level, in agreement with previous data obtained with other medicinal plants, such as *Lavandula angustifolia* Mill. ([@B14]), *Echinacea purpurea* and *Echinacea angustifolia* ([@B7]; [@B32]). Therefore, different endophytic bacterial species are selected not only at the root or stem level, but also within plant tissues, as the different distribution of genera could suggest. Hence, it is possible that plant might "select" specific taxa to access its compartments.

In this work we have analyzed the antibiotic resistance profile of 62 cultivable bacterial strains isolated from different anatomical parts of *O. vulgare* plant and from the bulk soil. The obtained data revealed that: (i) most of the strains showed tolerance to at least the lowest concentrations of the antibiotic streptomycin and kanamycin used, and only a few strains were able to grow in presence of low concentrations of the antibiotic chloramphenicol and ciprofloxacin; a similar trend has already been evidenced in the case of *E. purpurea* ([@B37]); (ii) only a small number of strains (2 out of 19) tolerated the lowest concentrations of rifampicin; (iii) strains associated to the bulk soil resulted resistant against the great majority of the antibiotics tested, even at the highest concentrations used. The high tolerance to both streptomycin and kanamycin, shown by tested strains, could be due to similar resistance mechanisms. Moreover, the high resistance of strains associated to the bulk soil might be probably due to their exposure to commonly used antibiotics: in this scenario, their greater resistance to antibiotics could be explained.

Antagonistic inter and intra- compartment interactions were also evaluated. These analyses suggested that the bacterial communities from the stem and the soil compartments were particularly able to antagonize the growth of bacteria belonging to the other two compartments. Moreover, stem community revealed the highest self-inhibition levels, whereas flower-associated bacteria revealed the lowest one. Thus, the different antagonistic activity observed could be (apparently) influenced by the ecological niche inhabited by bacteria. Overall, the obtained results suggest that antagonistic interactions between bacterial strains might play a role in driving the diverse composition of the bacterial communities in the anatomical districts of the plants. It is important to stress that the used medium could influence the inhibitory patterns, and also that in different environmental conditions the inhibitory patterns could be different: for example, strains that do not show any inhibition on plates, *in vivo* could be stronger antagonists, and *vice versa*.

Strains that exhibited high inhibitory properties were tested against multidrug resistant human pathogens. Interestingly, regarding the antagonistic activity against BCC, *O. vulgare* strains were much more able to inhibit the growth of BCC members isolated from CF patients than those of environmental origins. On the other hand, 47.8% of *O. vulgare* strains showed antagonistic activity against at least one human pathogenic strain among *S. aureus*, Coagulase-negative staphylococci (CoNS), *P. aeruginosa* and *K. pneumoniae*, with the most active isolates displaying greater capacity of inhibition mainly against Gram-positive bacteria than Gram-negative ones. It has been proposed that, regarding Gram-negative bacteria, the presence of the outer polysaccharide membrane (made of various lipopolysaccharide constituents) could make them impermeable to lipophilic solutes ([@B54]; [@B42]).

At the same time, we can speculate that the different antimicrobial activity can depend on the different type of habitats that bacteria occupy: *Staphylococcus aureus* and CoNS are common colonizers of human epithelia, while *P. aeruginosa* and *K. pneumoniae* are opportunistic pathogens widely recovered from the environment. Hence, it is reasonable that bacteria capable of colonizing environmental habitats can exhibit intrinsic or acquired resistance against antimicrobial compounds produced by competing bacteria commonly found in the same ecological niches. Further studies should be performed to better understand this behavior.

In our opinion, data obtained in this work offer a preliminary but very promising example of the biotechnological potential of bacteria isolated from medicinal plants. In fact, the majority of the tested strains revealed a marked inhibitory effect between different compartments, widespread resistance to common antibiotics, and a strong capacity to inhibit the growth of MDR human pathogens. This last point is very important: nowadays research for new molecules active against human pathogens (MDR in particular) is one of the most important goals to achieve, mainly due to the increased resistance to commercially used antibiotics, an inevitable side effect of both the unsuitable use and over prescription of antibiotics in human medicine therapy and the antibiotics released into the environment ([@B18]). As known, medicinal plants and their associated microbiome represent a natural *reservoir* for bioactive compounds of pharmacological interest. Therefore, the bioactive compounds of selected strains could be purified and then tested for their bioactivity (or cytotoxicity) on human cultures and on animal models; it could be interesting to find out if the production of antimicrobial molecules in *O. vulgare* could be dependent on its associated microbiota. Furthermore, this study suggests that antagonistic interactions between bacterial strains might play a role in driving the diverse composition of the bacterial communities in the anatomical districts of the plants.
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